Council of Advisors
Douglas Augenthaler
Doug has a BS in Finance Boston College and is a CFA. He was an equity analyst at Moody’s from 1978-1980, EF Hutton from 1980-1987, Dean Witter from 1987-1989 and Oppenheimer & Co./CIBC from 1989-2002. During his sell-side career, Doug covered the environmental, industrial biotechnology and technology sectors. From 2003-present, Doug has been a Portfolio Manager, at Highbrace Capital, a Fund of Hedge Funds. Doug is a several time Institutional Investor All American and Wall Street Journal All-Star.
Katherine Burdon, CFA
Cadence Capital Management, retired
Kathy is an independent portfolio manager. She has a more than 20 years of experience within asset management, accounting, and healthcare. Prior to her private practice, Kathy Burdon was a Senior Portfolio Manager at Cadence Capital Management, responsible for the Mid- and Small-Cap strategies. Ms. Burdon received her B.S. in biology from Stanford University and an M.S. in accounting from Northeastern University. She is a Chartered Financial Analyst.
Kathy lives in Boston and Westport, MA. She is an accomplished tennis player, equestrienne and skier.
Lucylee Chiles, EdD
Lucylee Chiles holds a doctorate in Art and Education from Columbia University and has extensive experience in non-profit governance. She has served as the Director of a non-profit institution for many years. These include having been the Director of the Isabel O’Neil Studio Workshop and Foundation from 1994 – 2002; having served as adjunct Art faculty at Kean University from 2003-2005; and having served on the Board of Trustees of International House in New York and the University Council for Arts Education.
George Demetri, MD
Dana Farber Cancer Institute/Harvard University
Dr. Demetri is a medical oncologist at the Dana Farber Institute and is a key-opinion-leader in sarcomas and gastro-intestinal stromal tumors (GIST). Dr. Demetri received his MD from Stanford University in 1983, followed by an internal medicine residency and chief residency at the University of Washington Hospital, Seattle, and a fellowship in medical oncology at Dana Farber Cancer Institute (DFCI) in 1989. He is director of the Center for Sarcoma and Bone Oncology at DFCI, director of the Ludwig Center at Dana-Farber/Harvard Cancer Center, and executive director for Clinical and Translational Research at the Ludwig Institute for Cancer Research.
Kathleen Denis, Ph.D.
The Rockefeller University
Dr. Denis is the Associate Vice President of Technology Transfer at The Rockefeller University, a premier biomedical research institution located in New York City. Managing the intellectual assets of the University, she works with their elite group of researchers to establish partnerships with industry in order to develop and commercialize technologies for the public good. Formerly a consultant specializing in the management of intellectual assets in the life sciences, she worked with academic and industry clients to manage intellectual property portfolios, evaluate new technologies, market and license technologies and start new technology-based businesses.
Dr. Denis is active in numerous professional organizations and speaks frequently about early stage technology evaluation, formation of start-up companies, conflict of interest and other issues of academic technology transfer. She is a Past President of the Licensing Executives Society USA/Canada (LES), and has served on the Board of Directors of the Association of University Technology Managers (AUTM) and the Pennsylvania Biotechnology Association.
From 1995 through 1998 Dr. Denis was Vice President, Technology Development at Allegheny Health, Education and Research Foundation. She managed the intellectual property and research assets of the Medical College of Pennsylvania and Hahnemann University, as well as Allegheny General Hospital and Allegheny Singer Research Institute. Responsibilities of this position included the evaluation and marketing of technologies, building collaborative relationships with the biomedical and biopharmaceutical communities and promotion of economic development in Pennsylvania.
Dr. Denis was a Director at the University of Pennsylvania Center for Technology Transfer from 1991 to 1995, where she managed a large portfolio of biotechnology and pharmaceutical related technologies. Previously, she was an investigator at the Molecular Biology Institute at UCLA for eight years, and a Senior Scientist at Specialty Laboratories, Inc. She has over thirty scientific publications.
Dr. Denis holds a Ph.D. in immunology from the University of Pennsylvania, an M.A. in Human Genetics from University of Texas Medical Branch at Galveston and an undergraduate degree in genetics from Cornell University.
Joan Ryan Gregory
Zurich Scudder Investments, retired
Joan is a former Senior Vice President of Zurich Scudder Investments, the New York-based money management firm, and a member of the firm’s international portfolio management team.
Prior to joining Scudder in 1992, Joan was an Associate Portfolio Manager with United States Trust Company of New York and Accounts Manager for the Young Presidents Organization. She received her B.A. in French and Spanish Literature from the University College in Dublin, Ireland, her M.A. in French Literature from Marquette University, and her Masters in International Affairs from Columbia University’s School of International and Public Affairs.
Ms. Gregory is a citizen of Ireland.
Lily Hayes
Bristol Myers Squibb
Lily Hayes currently serves as a territory manager in the specialty pharmaceuticals division of Bristol Myers Squibb. Prior to joining BMS, Lily held marketing and communications positions with Pfizer and Amgen. Miss Hayes holds a degree in biology from the University of Richmond where she graduated cum laude and was a member of the biology honor society, Beta Beta Beta. In addition to serving as a Trustee of the Hope Funds for Cancer Research, she volunteers for the Mayflower Foundation and is member of the Junior League of Boston.
Kim Herrlinger
Kim resides in Newport, RI and Round Hill Jamaica. She has experience serving on several non-profit boards including the Newport Art Museum and Association and the Boys and Girls Club of Newport, RI. Mrs. Herrlinger is the chairwoman of the House Committee of the Marble House in Newport, RI. In addition, Kim has chaired several very successful special events for the Preservation Society of Newport County, including their summer dances and Christmas dances; and events for Round Hill Charities in Jamaica. In addition to her extensive volunteer activities, Mrs. Herrlinger is an accomplished golfer and tennis player.
Bill Jacklin RA
Royal Academy of Art
Bill is renowned for his portraits of the city, particularly New York and London, and more recently Hong Kong and now Venice. Bill primarily resides and works in New York City and Newport, RI.
Jacklin, born in London in 1943, attended Walthamstow Art School in Essex from 1960-61 and in 1967 received an M.A. from the Royal College of Art. In 1991 he was elected a Royal Academician and in 1991 he spent three months in Hong Kong as the British Council’s first artist-in-residence. The Museum of Modern Art, Oxford, honored him with a retrospective exhibition Urban Portraits 1986-1992, which then traveled to Santiago de Compostela in Spain.
Jacklin’s work can be found in many public collections including: The British Museum; Boymans-van-Beuningen Museum, Rotterdam; Metropolitan Museum of Art, New York; Museum of Modern Art, New York; Museum of Fine Arts, Budapest, Tate Britain; Thyssen-Bornemisza Museum, Madrid; Victoria & Albert Museum; Yale Center for British Art, New Haven.
Bill is represented by Marlborough Galleries, where he has had numerous exhibits in New York, London and Madrid.
Susan Killebrew MSW
Killebrew Capital Management
Susan is a trained therapist and social worker and lives in New York City and Newport, RI. Susan holds a BA from Salve Regina in Newport and a master’s degree from Boston University. She has served the public sector by attending patients in the public schools in RI and has been in private practice. She is currently Vice president and Treasurer of Killebrew Capital Advisors, an investment concern that raises assets for hedge-fund managers, including Merlin Biomed and Argent Financial Group. In addition to her professional life, Susan is a board member of the Star Kids in Newport, RI and the Boys and Girls Club of Newport, RI.
Paula Kim
Tranlating Research Across Communities
Paula Kim, Founder and President, Translating Research Across Communities (TRAC) and Principal of Paula Kim Consulting is recognized for her work in advocacy and bridging the gap between the research community and those with whom they must collaborate to accelerate research that benefits patients.
Ms. Kim’s father died from pancreatic cancer in 1998, just seventy-five days after his diagnosis. Throughout her father’s illness and afterwards, she used the Internet to connect with researchers, patients, and families affected by pancreatic cancer. The tremendous need for improvement in patient services, early detection, treatments, awareness, and research funding for the disease was evident. Her lack of knowledge and experience in advocacy, public policy, and research did not diminish her determination to make a difference. In 1999, she co-founded the Pancreatic Cancer Action Network (PanCAN), the disease’s first and only national patient advocacy organization, serving as Chair and CEO between 1999 and 2004. During her tenure, PanCAN developed the first national programs for pancreatic cancer in patient services, national grassroots volunteer awareness, and privately funded career-development grants.
Ms. Kim’s involvement with the patient, research, agency, and industrial communities is an important focus of her efforts and she was recently honored with the 2006 Society of Surgical Oncology James Ewing Layman Award, the 2004 American Association for Cancer Research (AACR) Public Service Award and the 2004 American Society of Clinical Oncology (ASCO) Partners in Progress Award.
In addition to her professional work, Ms. Kim maintains longstanding commitments to volunteer service that preceded PanCAN and continues with service to the National Cancer Institute, the Food and Drug Administration, as well as with many researchers, cancer centers, and organizations around the world.
Adrian G. Looney, PhD, JD
Pfizer
Adrian received his B.Sc. degree in Chemistry from University College Cork, Ireland in 1988. Upon graduation he commenced studies at Columbia University in Chemistry and was awarded three degrees, M.A., M.Phil., Ph.D. He then joined a law firm in New York in 1993 as a scientific advisor and subsequently studied for a degree in law from New York Law School. In 2000 Adrian joined Pfizer and is currently the Global Intellectual Property Leader for Cancer. Adrian is a trustee of International House, where he co-chairs the Council of World Members and serves on the Development Committee.
Marc Lewinstein
Kirkland & Ellis LLP
Marc Lewinstein is a restructuring attorney in the New York office of Kirkland & Ellis LLP and a member of the bars of New York and Massachusetts. Prior to joining Kirkland, Marc worked at Cahill Gordon & Reindel LLP, Lehman Brothers, Inc., Dickstein Shapiro LLP and Berkshire Capital Corporation. Marc was graduated from Cornell Law School and Dartmouth College.
In addition to serving as the co-chair of the Hope Funds 2008 Gala Junior Committee, Marc is Vice Chairman and Benefit Committee Co-Chairman of the Special Olympics New York Junior Committee and a member of the Cornell Law School Annual Fund Young Alumni Committee and Dean’s Leadership Council. He has received the Dartmouth College Fund’s Mark Alperin Award for Outstanding Class Leadership.
Paul D. Maxwell
Monitor Clipper Partners
Paul Maxwell is a Principal at Monitor Clipper Partners, a private equity firm based in Boston. Paul began his career as an investment banking analyst at Salomon Smith Barney in New York. His prior experience also includes working for Merrill Lynch in London and for Fenway Partners, a private equity firm based in New York.
Alessandro Papa, M.D.
Newport Hospital
Alex is a hematologist/oncologist practicing at Newport Hospital in Newport, RI. Dr. Papa received his BS and MD from Brown University.
Bettie Bearden Pardee
Bettie is a writer, editor, and producer. She is the author of Newport At Home and in the Garden, as well as several books on entertaining and travel. For eleven years Mrs. Pardee was a contributing editor for the magazine, Bon Appetit, where she produced the on-location feature Entertaining With Style. She hosted the PBS series The Presidential Palate: Entertaining at the White House. Bettie was raised in Beverly Hills, and has lived in Atlanta, Boston and New York City. A talented gardener and floral designer, Mrs. Pardee chairs the Newport Flower Show and is a flower-arranging judge with the Garden Club of America. She is also the Garden Club of America Zone II chairman for Garden History and Design. Her personal garden at Parterre is being documented for the Smithsonian Institution’s Archives of American Gardens.
Mrs. Pardee received a BA in Fine Arts from the University of California in Los Angles. She has served as a trustee of the Redwood Library and Athenaeum and the Boys & Girls Club of Newport and is a member of the House Committee of Rosecliff, the Preservation Society of Newport County’s property that adjoins her gardens.
Michael Rhea
Mr. Rhea has a background in financial services, with a focus on the biopharmaceutical industry. Mr. Rhea served as a Managing Director, Institutional Sales at Merriman Curhan Ford and Soleil Securities, and a Vice-president, Institutional Equity Sales at CIBC Oppenheimer and Lehman Brothers. In addition to institutional sales, Mr. Rhea served as a Managing Director in Investment Banking at Paramount Biocapital. Prior to beginning his financial services career in 1986, Mr. Rhea practiced corporate and securities law with Lester Schwab Katz and Dwyer and with Conboy Hewitt. Mr. Rhea holds a B.A. and J.D. degrees from Tulane University.
Steven A. Richter
Wellington Management Company
Mr. Richter is a Global Industry Analyst with Wellington Management Company following and investing in the global retail industry. He has more than 20 years of experience in equity research, investment banking and capital markets. Prior to joining Wellington, Steve was a senior equity research analyst for RBC Capital Markets in Boston focusing specialty retailers and branded apparel companies. Mr. Richter is a Chartered Financial Analyst and received his BA degree in Political Science from U.C.L.A. and his MBA degree from the University of Southern California. Mr. Richter currently lives in Hong Kong and Newport, RI with his wife and three children.
Richard L. Robbins
AG Edwards, retired
Richard recently retired from a 30-year career on Wall Street. He started his career in institutional sales at Oppenheimer & Co. and then moved to Lehman Brothers. After Lehman Brothers, Richard opened the Boston office for AG Edwards and remained there until his retirement in the fall of 2006. Richard attended Hamilton College and Duke Law School.
Mr. Robbins has been a strong cancer patient advocate and supporter. Richard resides in New York, Newport and Palm Beach. He is an avid tennis player.
Nathan Robison
Dr. Robison has been a Clinical Fellow in Pediatric Hematology/Oncology at Childrens Hospital, Los Angeles. He received his medical degree from University of Southern California Keck School of Medicine and his undergraduate degree from Williams College. Dr. Robinson is Board Certified in Pediatrics. In addition to his work at Childrens Hospital, Dr. Robison has done two volunteer tours in Rwanda. Dr. Robinson is a member of Alpha Omega Alpha honor society, Association of Pathology, Christian Medical Association, American Society of Pediatric Hematology and Oncology, American Association of Cancer Research, and the American Society for Blood and Marrow Transplant. Nathan currently holds a Hope Funds for Cancer Research Post Doctoral Fellowship, which ends in June, at the time he accepts his appointment as a Fellow at Childrens Hospital/Harvard University.
Ayesha Sitlani, PhD
Merck & Company
Ayesha Sitlani is a Senior Research Fellow in the Cardiovascular Diseases Department at Merck & Co, Inc., NJ. Dr. Sitlani currently manages a large group of scientists, across different sites at Merck, to develop novel ways to treat and manage heart disease.
Dr. Sitlani received her B.A. degree in Chemistry from Smith College, MA in 1988, her M.A. degree in Chemistry from Columbia University, NYC in 1989, and her Ph.D. in Biochemistry from the California Institute of Technology in 1993. Upon graduating, Dr. Sitlani received a Jane Coffin Childs Cancer Research Postdoctoral Fellowship to work on understanding the principles of gene regulation at Yale University, CT. Upon completion of her postdoctoral work in 1998, Dr. Sitlani joined Merck & Co., Inc. in Rahway, NJ as a Senior Research Scientist where she focused first on identifying better anti-inflammatory therapies. During the past four years, Dr. Sitlani has been working on identifying new ways to manage and treat heart disease. She currently manages a large group of scientists across different Merck sites towards this goal. Dr. Sitlani is an author of several peer reviewed articles and is an active member of the scientific community.
Joseph Swiader
Joe Swiader is the owner of Wet Earth Partners, LLC, a biotechnology consulting firm located in Rhode Island. Mr. Swiader was a Biotechnology/Healthcare Analyst at Feirstein Capital Management from June 1997 to January 2000. This was a billion dollar hedge fund investing globally in healthcare. Prior to Feirstein Capital, Joe held biotechnology positions at Scudder, Stevens & Clark, Dreyfus and JP Morgan. Mr. Swiader holds a bachelors degree from Babson College.